This inactivation leads to a cancer-prone phenotype, which is also accompanied by severe deficiency in development, and by neurological disorder when XPG mutations are associated with Cockayne syndrome (CS), to produce a complex disease (XPG/CS) [8,9,10]. The gene discussed is ERCC5; the disease is cancer.